Table 2 Antibodies used in this study

From: Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties

Primary antibody

Source

Catalog #

β-actin

Cell Signaling Technology (Danvers, MA, USA)

4970L

AR

Santa Cruz Biotechnology (Dallas, TX, USA)

7305

E-cadherin

BD Biosciences (Franklin Lakes, NJ, USA)

610181

FN1

BD Biosciences

610077

FOXC2

Dr Nayoyuki Miura

NA

N-cadherin

BD Biosciences

610920

p38

Cell Signaling Technology

9212S

pATF2

Cell Signaling Technology

9221S

p-p38

Cell Signaling Technology

4511S

PSA

Santa Cruz Biotechnology

7638

Snail

Santa Cruz Biotechnology

28199

Total-ATF2

Cell Signaling Technology

9226S

Vimentin

Novus Biologicals (Littleton, CO, USA)

H00007431-M01

Zeb1

Santa Cruz Biotechnology

25388

  1. Abbreviation: NA, not applicable.